ES8606305A1 - Un procedimiento para la preparacion de nuevos derivados de triazina - Google Patents

Un procedimiento para la preparacion de nuevos derivados de triazina

Info

Publication number
ES8606305A1
ES8606305A1 ES539654A ES539654A ES8606305A1 ES 8606305 A1 ES8606305 A1 ES 8606305A1 ES 539654 A ES539654 A ES 539654A ES 539654 A ES539654 A ES 539654A ES 8606305 A1 ES8606305 A1 ES 8606305A1
Authority
ES
Spain
Prior art keywords
triazine derivatives
processes
preparation
same
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES539654A
Other languages
English (en)
Other versions
ES539654A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES8606305A1 publication Critical patent/ES8606305A1/es
Publication of ES539654A0 publication Critical patent/ES539654A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Color Electrophotography (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE NUEVOS DERIVADOS DE TRIAZINA. CONSISTE EN REDUCIR UN C.D.F (II) O SUS SALES CON UN HIDRURO METALICO COMO BOROHIDRURO DE LITIO O BOROHIDRURO SODICO, EN AGUA O ALCOHOL PARA OBTENER NUEVOS DERIVADOS DE TRIAZINA D.F. (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, TALES COMO SALES DE ADICION DE ACIDOS INORGANICOS Y ORGANICOS Y COMO SALES CON METALES ALCALINOS O ALCALINOTERREOS. SIENDO: R1 H O HAL; R2, HIDROXI, HIDROXI PROTEGIDO, AMINO, CIANO, MERCAPTO O ALQUILTIO INFERIOR Y X O O S. SE UTILIZA COMO ANTIHIPERTENSIVO PARA EL TRATAMIENTO DE LA HIPERTENSION, COMO ANTITROMBOTICO PARA EL TRATAMIENTO DE LA TROMBOSIS Y COMO ANTIULCEROSO PARA TRATAR LAS ULCERAS EN ANIMALES Y EN LOS SERES HUMANOS.
ES539654A 1983-04-22 1985-01-17 Un procedimiento para la preparacion de nuevos derivados de triazina Expired ES8606305A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58072013A JPS59196874A (ja) 1983-04-22 1983-04-22 トリアジン誘導体

Publications (2)

Publication Number Publication Date
ES8606305A1 true ES8606305A1 (es) 1986-04-16
ES539654A0 ES539654A0 (es) 1986-04-16

Family

ID=13477098

Family Applications (3)

Application Number Title Priority Date Filing Date
ES531793A Granted ES531793A0 (es) 1983-04-22 1984-04-18 Un procedimiento para la preparacion de nuevos derivados de triazina.
ES539654A Expired ES8606305A1 (es) 1983-04-22 1985-01-17 Un procedimiento para la preparacion de nuevos derivados de triazina
ES539653A Granted ES539653A0 (es) 1983-04-22 1985-01-17 Un procedimiento para la preparacion de nuevos derivados de triazina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES531793A Granted ES531793A0 (es) 1983-04-22 1984-04-18 Un procedimiento para la preparacion de nuevos derivados de triazina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES539653A Granted ES539653A0 (es) 1983-04-22 1985-01-17 Un procedimiento para la preparacion de nuevos derivados de triazina

Country Status (15)

Country Link
US (1) US4618610A (es)
EP (1) EP0123254B1 (es)
JP (1) JPS59196874A (es)
KR (1) KR840008341A (es)
AT (1) ATE35259T1 (es)
AU (1) AU2701584A (es)
DE (1) DE3472255D1 (es)
DK (1) DK201684A (es)
ES (3) ES531793A0 (es)
FI (1) FI841527A (es)
GR (1) GR81788B (es)
HU (1) HU192010B (es)
NO (1) NO841594L (es)
PH (1) PH20020A (es)
ZA (1) ZA842700B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4898862A (en) * 1986-03-20 1990-02-06 Sankyo Company Limited 1,2,4-triazinone derivatives, their preparation and use
GB8903130D0 (en) * 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
DE4239540A1 (de) * 1992-11-25 1994-05-26 Asta Medica Ag Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung
DE19929781A1 (de) * 1999-06-29 2001-01-04 Bayer Ag N-[4-(6-Oxotetrahydrotriazinyl)phenyl]amide und ihre Verwendung
EP2532239A3 (en) * 2007-04-03 2013-03-13 E. I. du Pont de Nemours and Company Substituted benzene fungicides
EP3661917B1 (en) 2017-08-04 2022-05-11 Bayer Aktiengesellschaft 6-((3-trifluoromethyl)phenyl)-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating cancer
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
WO2020157194A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft 1,2,4-triazin-3(2h)-one compounds for the treatment of hyperproliferative diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0052442B1 (en) * 1980-11-14 1985-09-11 Imperial Chemical Industries Plc Heterocyclic compounds
US4616014A (en) * 1981-10-22 1986-10-07 Fujisawa Pharmaceutical Co., Ltd. Triazine derivatives, and pharmaceutical compositions comprising the same
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
GB8310435D0 (en) * 1983-04-18 1983-05-25 Fujisawa Pharmaceutical Co Triazine derivatives

Also Published As

Publication number Publication date
KR840008341A (ko) 1984-12-14
EP0123254A1 (en) 1984-10-31
ES8602706A1 (es) 1985-11-16
ZA842700B (en) 1984-11-28
JPS59196874A (ja) 1984-11-08
ES8507517A1 (es) 1985-09-01
DE3472255D1 (en) 1988-07-28
ES531793A0 (es) 1985-09-01
FI841527A (fi) 1984-10-23
EP0123254B1 (en) 1988-06-22
NO841594L (no) 1984-10-23
ES539654A0 (es) 1986-04-16
GR81788B (es) 1984-12-12
HUT34173A (en) 1985-02-28
ATE35259T1 (de) 1988-07-15
HU192010B (en) 1987-04-28
DK201684A (da) 1984-10-23
PH20020A (en) 1986-09-01
JPH0235752B2 (es) 1990-08-13
FI841527A0 (fi) 1984-04-17
AU2701584A (en) 1984-10-25
US4618610A (en) 1986-10-21
DK201684D0 (da) 1984-04-18
ES539653A0 (es) 1985-11-16

Similar Documents

Publication Publication Date Title
KR940007270B1 (en) Quinazoline derivatives
ATE206412T1 (de) Heterocyclische verbindungen als bradykinin antagonisten
BG103417A (en) Condensed pyrimidine bicyclic derivatives
WO1996016981A3 (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
SE8107273L (sv) 2-oxoazetidinderivat, sett att framstella democh anvendning derav
ES8606305A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina
NO905620D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
ZA868665B (en) Amino acid derivatives
ES2001697A6 (es) Procedimiento para preparar 2-aminopurinas sustituidas en posiciones 6 y 9
DE69330601D1 (de) Serotoninergische ergolin derivate
DE10299023I2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
FI895139A0 (fi) Pyrrolidinderivat.
ES8506643A1 (es) Procedimiento para la preparacion de derivados d,l-, d-y l-del acido 3-imidazolil-2-amino-propionico
DK0674645T3 (da) Cephemforbindelser med antimikrobiel virkning
EA199800575A1 (ru) Производные пиперазина